Skip to main content
TipRanks
Go Ultimate75% OFF

Modern Healthcare Technology Holdings Limited (0919) AI Stock Analysis

0 Followers
HK:0919

Modern Healthcare Technology Holdings Limited

(HKEX:0919)

Select Model
Rating:48Neutral
Price Target:HKD 0.07â–¼(-1.33% Downside)
Action:reiterated
Date:11/06/26

The score is primarily constrained by persistent losses, severe margin compression, declining revenue, and weak technical positioning. Positive operating cash flow and reduced leverage provide meaningful support, but they do not yet offset the lack of sustainable profitability and the negative P/E ratio.

Positive Factors
Positive Cash GenerationConsistently positive operating and free cash flow indicates the business is converting operations into funding despite accounting losses. This supports ongoing liquidity, reduces reliance on external financing, and provides resources for operations and investment over the next several quarters.
Negative Factors
Persistent Net LossesPersistent net losses show that improved operating performance has not yet translated into positive bottom-line returns. This limits retained earnings growth, weakens shareholder profitability, and leaves the company exposed if operating gains fail to cover other costs.

Modern Healthcare Technology Holdings Limited (0919) vs. iShares MSCI Hong Kong ETF (EWH)

-10%0%10%20%30%40%50%HK:0919+2.74%EWH+8.17%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
HKD 67.84M
Dividend Yield
―
Average Volume (3M)
160.85K
Price to Earnings (P/E)
-37.5
Beta (1Y)
0.48
Revenue Growth
-2.31%
EPS Growth
66.07%
Country
Hong Kong
Employees
783
Sector
Consumer Cyclical
Sector Strength
61
Industry
Personal Products & Services

Modern Healthcare Technology Holdings Limited Business Overview & Revenue Model

Company Description

Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, Mainland China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skinca...

Modern Healthcare Technology Holdings Limited Financial Statement Overview

Summary

Financial performance is mixed: positive operating and free cash flow, lower debt, and a solid equity base are offset by five consecutive years of losses, sharply lower gross margins, declining revenue, and weakening recent cash-flow momentum.

Income Statement

42Neutral

Balance Sheet

58Neutral

Cash Flow

65Positive
Financial statement breakdown
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue444.52M442.81M453.27M454.71M406.33M355.59M
Gross Profit126.99M91.89M165.26M166.96M394.72M341.52M
EBITDA113.89M108.17M77.11M95.68M70.72M26.39M
Net Income-1.76M-1.76M-5.07M-9.57M-20.61M-68.81M
Balance Sheet
Total Assets521.38M521.38M564.46M611.04M561.35M570.96M
Cash, Cash Equivalents and Short-Term Investments305.63M305.63M236.67M193.66M177.53M127.53M
Total Debt43.50M43.50M68.65M106.57M40.11M65.01M
Total Liabilities328.34M328.34M373.26M416.65M357.47M347.75M
Stockholders Equity186.68M186.68M185.85M189.33M199.77M219.58M
Cash Flow
Free Cash Flow77.06M77.06M134.94M64.08M125.52M-29.55M
Operating Cash Flow80.12M80.12M151.09M78.66M139.82M51.31M
Investing Cash Flow4.58M5.57M-50.50M8.16M-13.17M-79.96M
Financing Cash Flow-62.31M-62.31M-66.24M-70.60M-77.31M-78.46M

Modern Healthcare Technology Holdings Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price0.07

Price Trends

50DMA0.08Negative
100DMA0.08Negative
200DMA0.09Negative

Market Momentum

MACD-0.00Negative
RSI31.77Neutral
STOCH80.00Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0919, the sentiment is Negative. The current price of 0.07 is below the 20-day moving average (MA) of 0.08, below the 50-day MA of 0.08, and below the 200-day MA of 0.09, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 31.77 is Neutral, neither overbought nor oversold. The STOCH value of 80.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0919.

Modern Healthcare Technology Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

HK:0919 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:1830HK:183077OutperformHKD 1.98B11.1043.78%9.21%-14.68%-13.60%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
HK:1448HK:144856NeutralHKD 6.03B14.026.50%6.27%――
HK:2521HK:252152NeutralHKD 1.75B48.106.47%―2.78%-41.23%
HK:8483HK:848350NeutralHKD 280.00M-27.70-77.06%―-38.43%-394.12%
HK:0919HK:091948NeutralHKD 67.84M-37.50-0.93%―-2.31%66.07%
HK:8296HK:829643NeutralHKD 15.12M-0.64-17.95%―-26.00%-188.55%

* Consumer Cyclical Sector Average

Performance Comparison

-50%0%50%100%150%HK:0919HK:1448HK:1830HK:8296HK:8483HK:2521Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HK:0919 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:0919Modern Healthcare Technology Holdings Limited0.070.002.74%
HK:1448Fu Shou Yuan International Group 2.64-0.27-9.31%
HK:1830Perfect Medical Health Management Limited1.580.3528.25%
HK:8296Sino-Life Group Limited0.16-0.22-57.89%
HK:8483Max Sight Group Holdings Limited0.350.21150.00%
HK:2521Shenghui Cleanness Group Holdings Limited0.900.4287.50%

Modern Healthcare Technology Holdings Limited Corporate Events

Modern Healthcare Technology Sets Out Board and Committee Structure

Aug 28, 2026

Modern Healthcare Technology Holdings Limited has announced the current composition of its board of directors, naming Dr. Tsang Yue, Joyce as Chairperson and Chief Executive Officer, supported by two other executive directors and three independent no...

Modern Healthcare Technology Flags Lease Deals After Disclosure Oversight

Aug 28, 2026

Modern Healthcare Technology Technology Holdings Limited disclosed that four wholly-owned subsidiaries entered into lease agreements for premises in Hong Kong and Singapore between April and September 2025, supporting their office, retail and service...

Modern Healthcare Technology Clears All AGM Resolutions and Reshuffles Board Committees

Aug 28, 2026

Modern Healthcare Technology Holdings Limited reported that all resolutions at its 28 August 2026 annual general meeting were approved by poll, including adoption of the 2026 financial statements, re-election of directors, reappointment of KPMG as au...

Modern Healthcare Technology Details Higher Audit Fee in KPMG Reappointment Plan

Aug 13, 2026

Modern Healthcare Technology Holdings Limited has issued a supplemental announcement ahead of its annual general meeting, detailing plans to retain KPMG as its external auditor for another year. The proposal, supported by the company’s audit committe...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026